Interim analysis (IA) of OPTIC: A dose-ranging study of three ponatinib (PON) starting doses.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.7502
Abstract: 7502Background: In PACE (NCT01207440) heavily pretreated patients (pts) with chronic-phase CML (CP-CML) had deep, lasting responses to PON; long-term follow-up showed increasing rates of arterial o... read more here.
Keywords: dose ranging; analysis optic; interim analysis; ranging study ... See more keywords